ES2103691A1 - Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales. - Google Patents

Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.

Info

Publication number
ES2103691A1
ES2103691A1 ES09600614A ES9600614A ES2103691A1 ES 2103691 A1 ES2103691 A1 ES 2103691A1 ES 09600614 A ES09600614 A ES 09600614A ES 9600614 A ES9600614 A ES 9600614A ES 2103691 A1 ES2103691 A1 ES 2103691A1
Authority
ES
Spain
Prior art keywords
extract
papillomas
warts
mycosis
euphorbia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES09600614A
Other languages
English (en)
Other versions
ES2103691B1 (es
Inventor
Mazario Adolfo Garijo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to ES9600614A priority Critical patent/ES2103691B1/es
Priority to AU19276/97A priority patent/AU1927697A/en
Priority to PCT/ES1997/000058 priority patent/WO1997033598A1/es
Publication of ES2103691A1 publication Critical patent/ES2103691A1/es
Application granted granted Critical
Publication of ES2103691B1 publication Critical patent/ES2103691B1/es
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

USO DEL EXTRATO DE EUPHORBIA CHARACIAS PARA LA FABRICACION DE UN MEDICAMENTO UTIL PARA EL TRATAMIENTO Y PREVENCION DE PAPILOMAS, VERRUGAS Y MICOSIS, EN HUMANOS Y ANIMALES. SE TRATA DE UNA NUEVA APLICACION EN MEDICINA. LAS PROPIEDADES CURATIVAS Y PREVENTIVAS DEL EXTRACTO DE EUPHORBIA CHARACIAS FRENTE A TUMORES EPITELIALES, PAPILOMAS, VERRUGAS Y MICOSIS EXTERNAS. EL EXTRATO DE EUPHORBIA SE MUESTRA COMO UN ACTIVO REGENERADOR EPITELIAL, A LA VEZ QUE EVITA LA COLONIZACION DE LA PIEL POR HUESPEDES EXTRAÑOS. LA APLICACION SE HACE EN FORMA EXTERNA. EL EXTRACTO, DILUIDO Y REBAJADO, ES UN PODEROSO ANTIMICOTICO. EFICAZ PARA TRATAR, DESDE UNA PTIRIASIS VERSICOLOR, HASTA EL PIE DE ATLETA. EN PLAZOS MUY INFERIORES A LOS DE LOS TRATAMIENTOS AHORA EMPLEADOS. A MAYOR DILUCION DEL LATEX, SIRVE DE PREVENTIVO, SOBRE TODO EN EL PIE, PARA HONGOS, VERRUGAS Y PAPILOMAS.
ES9600614A 1996-03-14 1996-03-14 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales. Expired - Fee Related ES2103691B1 (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ES9600614A ES2103691B1 (es) 1996-03-14 1996-03-14 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.
AU19276/97A AU1927697A (en) 1996-03-14 1997-03-11 Use of euphorbia characias extract for the fabrication of a medicament useful for the prevention and treatment of papillomas, warts and mycosis in humans and animals
PCT/ES1997/000058 WO1997033598A1 (es) 1996-03-14 1997-03-11 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES9600614A ES2103691B1 (es) 1996-03-14 1996-03-14 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.

Publications (2)

Publication Number Publication Date
ES2103691A1 true ES2103691A1 (es) 1997-09-16
ES2103691B1 ES2103691B1 (es) 1998-04-16

Family

ID=8294167

Family Applications (1)

Application Number Title Priority Date Filing Date
ES9600614A Expired - Fee Related ES2103691B1 (es) 1996-03-14 1996-03-14 Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.

Country Status (3)

Country Link
AU (1) AU1927697A (es)
ES (1) ES2103691B1 (es)
WO (1) WO1997033598A1 (es)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2342071A1 (fr) * 1975-10-16 1977-09-23 Ohf Etudes Participations Produit antiverruqueux et coricide
EP0279382A2 (de) * 1987-02-18 1988-08-24 Brigitte Lünemann Warzenmittel
EP0330094A1 (de) * 1988-02-25 1989-08-30 Eszter geb. Szénási Tamás Verwendung der Pflanze Euphorbia hirta L. und ihrer Extrakte sowie ihrer Wirkstoffe
DE4102054A1 (de) * 1991-01-24 1992-07-30 Geb Szenasi Tamas Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2342071A1 (fr) * 1975-10-16 1977-09-23 Ohf Etudes Participations Produit antiverruqueux et coricide
EP0279382A2 (de) * 1987-02-18 1988-08-24 Brigitte Lünemann Warzenmittel
EP0330094A1 (de) * 1988-02-25 1989-08-30 Eszter geb. Szénási Tamás Verwendung der Pflanze Euphorbia hirta L. und ihrer Extrakte sowie ihrer Wirkstoffe
DE4102054A1 (de) * 1991-01-24 1992-07-30 Geb Szenasi Tamas Verwendung der pflanze euphorbia hirta l. und ihrer extrakte sowie ihrer wirkstoffe

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BARBIERI, L. et al. Purification and properties of two lectins from the latex of the euphorbiaceous plants Hura crepitans L. (sand-box tree) and Euphorbia characias L. (Mediterranean spurge). Biochemical Journal, Diciembre 1983, Vol. 215, n‘ 3, pßginas 433-439 *
FONT QUER, P. Plantas Medicinales: El Dioscórides Renovado. Editorial LABOR, S.A. Barcelona, 1992, página 190, columna 2 *
MASSMANIAN, A. Severe contact dermatitis due to natural latex. Contact Dermatitis, 1995, Vol. 32, n‘ 6, pßginas 364-365 *

Also Published As

Publication number Publication date
ES2103691B1 (es) 1998-04-16
AU1927697A (en) 1997-10-01
WO1997033598A1 (es) 1997-09-18

Similar Documents

Publication Publication Date Title
KR101583746B1 (ko) 아미노산 및 히알루론산 나트륨에 기반한 크림 제형의상처-치료용 약학적 조성물
PL316651A1 (en) Gel for treating dermatoses and skin disinfecting
GR1002807B (el) Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του
ATE555782T1 (de) Prävention und/oder behandlung von kardiovaskulären erkrankungen und/oder damit zusammenhängender herzinsuffizienz
RU94045258A (ru) Косметическая или дерматологическая композиция для одновременного лечения поверхностных и глубоких слоев кожи и ее применение
BR0212252A (pt) Métodos para reduzir a hipertensão e a insuficiência cardìaca em um mamìfero
CY1109191T1 (el) Μια νεα χρηση της δεφεριπρονης
AU1865100A (en) Hyaluronate lyase used for promoting penetration in topical agents
CA2322878A1 (en) Use of selegiline or desmethylselegiline for treating wounds, burns and dermatological damage
CA2156481A1 (en) 5-ht2 receptor antagonist compositions useful in treating venous conditions
AU5116298A (en) The use of adamantane amines or structurally similar compounds for combating borna disease virus and for the prevention and treatment of affective diseases and other disorders associated with BDV infections in humans and animals
US7198794B1 (en) Topical formulation for treating fingernails and toenails
ES2103691A1 (es) Uso del extracto de euphorbia characias para la fabricacion de un medicamento util para la prevencion y tratamiento de papilomas, verrugas y micosis en humanos y animales.
Sandhu et al. Potassium iodide remains the most effective therapy for cutaneous sporotrichosis
DE69103773D1 (de) Derivate von hydroxaminsäure die lipoxygenase hemmen.
DE69424679D1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
Kumar et al. A comparative study of efficacy of silver stream versus povidone iodine in healing the diabetic ulcers
US20030228382A1 (en) Foot Fixer Kit
Lestringant et al. Effectiveness of amorolfine 5% nail lacquer in the treatment of long-duration Candida onychomycosis with chronic paronychia
Rutkowski et al. Split nails, abscesses, and cuticular fluid pockets
Molin Discoid lupus erythematosus lesions treated with cryosurgery
WO1998025594A3 (en) Lamotrigine in the treatment and prophylaxis of migraine
CA3089750A1 (en) Methods of treating and/or preventing bedsores using nabilone
RU94024337A (ru) Антиметастатическое средство
BR9914792A (pt) Uso de agentes antifúngicos para tratamento deescleroses

Legal Events

Date Code Title Description
EC2A Search report published

Date of ref document: 19970916

Kind code of ref document: A1

Effective date: 19970916

FD2A Announcement of lapse in spain

Effective date: 20180807